| Year |
Citation |
Score |
| 2019 |
Gao M, Bai H, Jethava Y, Wu Y, Zhu Y, Yang Y, Xia J, Cao H, Franqui-Machin R, Nadiminti K, Thomas GS, Salama ME, Altevogt P, Bishop G, Tomasson M, et al. Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma. Journal of the National Cancer Institute. PMID 31406992 DOI: 10.1093/Jnci/Djz159 |
0.318 |
|
| 2019 |
Ali M, Kowkuntla S, Delloro DJ, Galambos C, Hathi D, Janz S, Shokeen M, Tripathi C, Xu H, Yuk J, Zhan F, Tomasson MH, Bates ML. Chronic intermittent hypoxia enhances disease progression in myeloma-resistant mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. PMID 30892915 DOI: 10.1152/Ajpregu.00388.2018 |
0.379 |
|
| 2019 |
Glenn MJ, Madsen MJ, Davis E, Garner CD, Curtin K, Jones B, Williams JA, Tomasson MH, Camp NJ. Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees. Blood Cancer Journal. 9: 25. PMID 30808891 DOI: 10.1038/S41408-019-0186-8 |
0.317 |
|
| 2019 |
Nadiminti K, Strouse C, Sidiqi MH, Dozeman L, Mott SL, Schultz A, Claus J, Vikas P, Farooq U, Tomasson M, Silverman M, Jethava Y. Impact of Chemotherapy Based Induction Using Dexamethasone, Cisplatin, Doxorubicin, Cyclophosphamide and Etoposide (DPACE) Versus Novel Agent Induction in Patients Undergoing Tandem Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM) Biology of Blood and Marrow Transplantation. 25: S399-S400. DOI: 10.1016/J.Bbmt.2018.12.813 |
0.348 |
|
| 2018 |
White BS, Lanc I, O'Neal J, Gupta H, Fulton RS, Schmidt H, Fronick C, Belter EA, Fiala M, King J, Ahmann GJ, DeRome M, Mardis ER, Vij R, DiPersio JF, ... ... Tomasson MH, et al. A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5. Blood Cancer Journal. 8: 35. PMID 29563506 DOI: 10.1038/S41408-018-0062-Y |
0.605 |
|
| 2018 |
Kotagiri N, Cooper ML, Rettig M, Egbulefu C, Prior J, Cui G, Karmakar P, Zhou M, Yang X, Sudlow G, Marsala L, Chanswangphuwana C, Lu L, Habimana-Griffin L, Shokeen M, ... ... Tomasson M, et al. Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer. Nature Communications. 9: 275. PMID 29348537 DOI: 10.1038/S41467-017-02758-9 |
0.329 |
|
| 2018 |
Nadiminti K, Strouse C, Vikas P, Dozeman L, Schultz A, Berns G, Claus J, Mott SL, Farooq U, Silverman M, Tomasson M, Zhan F, Jethava Y. A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783) Blood. 132: 2153-2153. DOI: 10.1182/Blood-2018-99-118443 |
0.361 |
|
| 2018 |
Nadiminti K, Strouse C, Vikas P, Dozeman L, Schultz A, Mott SL, Claus J, Farooq U, Silverman M, Tomasson M, Zhan F, Jethava Y, Tricot GJ. Early Intensive Therapy in Multiple Myeloma Using Tandem Transplantation with Novel Conditioning and Two Years Maintenance: A Single Institution Experience Blood. 132: 2152-2152. DOI: 10.1182/Blood-2018-99-113890 |
0.363 |
|
| 2018 |
Du Z, Song C, Rand K, Weinhold N, Berg DVD, Hwang A, Sheng X, Hom V, Ailawadhi S, Nooka AK, Singhal S, Pawlish K, Peters ES, Bock C, Mohrbacher A, ... ... Tomasson M, et al. Abstract 223: A meta-analysis of genome-wide association studies of multiple myeloma among African Americans Cancer Research. 78: 223-223. DOI: 10.1158/1538-7445.Am2018-223 |
0.303 |
|
| 2017 |
Mahajan N, Wu HJ, Bennett RL, Troche C, Licht JD, Weber JD, Maggi LB, Tomasson MH. Sabotaging of the oxidative stress response by an oncogenic noncoding RNA. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 31: 482-490. PMID 28148777 DOI: 10.1096/Fj.201600654R |
0.348 |
|
| 2016 |
Welch JS, Petti AA, Miller CA, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Baty JD, Duncavage EJ, Tandon B, Lee YS, Wartman LD, Uy GL, Ghobadi A, Tomasson MH, et al. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. The New England Journal of Medicine. 375: 2023-2036. PMID 27959731 DOI: 10.1056/Nejmoa1605949 |
0.385 |
|
| 2016 |
Snee MJ, Wilson WC, Zhu Y, Chen SY, Wilson BA, Kseib C, O'Neal J, Mahajan N, Tomasson MH, Arur S, Skeath JB. Collaborative Control of Cell Cycle Progression by the RNA Exonuclease Dis3 and Ras is Conserved Across Species. Genetics. PMID 27029730 DOI: 10.1534/Genetics.116.187930 |
0.576 |
|
| 2016 |
Scott AD, Yellapantula VD, Yoon CJ, Wendl M, Tomasson MH, Fiala MA, DiPersio JF, Vij R, Ding L. Uncovering Clonal and Subclonal Druggable Targets in Multiple Myeloma Using Omic Data Blood. 128: 2084-2084. DOI: 10.1182/Blood.V128.22.2084.2084 |
0.355 |
|
| 2016 |
Chanswangphuwana C, Rettig MP, Akers W, Hathi D, Holt M, O'Neal J, Ritchey J, Kohnen D, King JA, Tomasson MH, Vij R, Shokeen M, DiPersio JF. Ex Vivo Evaluation of VLA-4 Expression in Primary Human Multiple Myeloma Bone Marrow Samples and In Vivo Mobilization of Murine Multiple Myeloma Cells with Small Molecule VLA-4 Inhibitors Blood. 128: 2056-2056. DOI: 10.1182/Blood.V128.22.2056.2056 |
0.596 |
|
| 2016 |
Fiala MA, Keller J, Sekhar J, Ceriotti C, Abboud CN, DiPersio JF, Tomasson MH, Wildes TM, Stockerl-Goldstein K, Vij R. A Phase II Study of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for Relapsed or Refractory Multiple Myeloma Blood. 128: 3329-3329. DOI: 10.1016/J.Clml.2017.03.102 |
0.323 |
|
| 2015 |
He Z, O'Neal J, Wilson WC, Mahajan N, Luo J, Wang Y, Su MY, Lu L, Skeath JB, Bhattacharya D, Tomasson MH. Deletion of Rb1 induces both hyperproliferation and cell death in murine germinal center B-cells. Experimental Hematology. PMID 26607597 DOI: 10.1016/J.Exphem.2015.11.006 |
0.602 |
|
| 2015 |
Amend SR, Wilson WC, Chu L, Lu L, Liu P, Serie D, Su X, Xu Y, Wang D, Gramolini A, Wen XY, O'Neal J, Hurchla M, Vachon CM, Colditz G, ... ... Tomasson MH, et al. Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types. Plos One. 10: e0127828. PMID 26020268 DOI: 10.1371/Journal.Pone.0127828 |
0.631 |
|
| 2015 |
Fiala MA, Finney JD, Stockerl-Goldstein KE, Tomasson MH, DiPersio JF, Vij R, Wildes TM. Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1153-4. PMID 25771403 DOI: 10.1016/J.Bbmt.2015.03.005 |
0.322 |
|
| 2015 |
Fiala MA, Finney JD, Liu J, Stockerl-Goldstein KE, Tomasson MH, Vij R, Wildes TM. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma. Leukemia & Lymphoma. 1-7. PMID 25651424 DOI: 10.3109/10428194.2015.1011156 |
0.344 |
|
| 2015 |
Welch JS, Petti A, Miller CA, Link DC, Walter MJ, Fronick CC, Fulton RS, Wartman LD, Uy GL, Ghobadi A, Tomasson M, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein K, et al. Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients Blood. 126: 689-689. DOI: 10.1182/Blood.V126.23.689.689 |
0.394 |
|
| 2015 |
Fiala MA, Wildes TM, Slade M, Keller J, Stockerl-Goldstein K, Tomasson M, Vij R. Variations in Multiple Myeloma Disease Presentation By Race Blood. 126: 5618-5618. DOI: 10.1182/Blood.V126.23.5618.5618 |
0.311 |
|
| 2015 |
White BS, Lanc I, Auclair D, Fulton R, Fiala MA, King J, Ahmann G, Derome M, Mardis ER, Levy J, Vij R, DiPersio JF, Tomasson M. A Second Generation, Multiple Myeloma-Specific, Targeted Sequencing Platform for Detecting Translocations, Copy Number Alterations, and Single Nucleotide Variants Blood. 126: 4207-4207. DOI: 10.1182/Blood.V126.23.4207.4207 |
0.378 |
|
| 2015 |
Keller J, Fiala MA, Slade M, Stockerl-Goldstein K, Tomasson M, Wildes TM, Vij R. Presenting Characteristics and Symptom Burden of Newly Diagnosed Older Multiple Myeloma Patients in the Commpass Study Blood. 126: 3307-3307. DOI: 10.1182/Blood.V126.23.3307.3307 |
0.312 |
|
| 2015 |
Fiala MA, Slade M, Keller J, Stockerl-Goldstein K, Tomasson M, Wildes TM, Vij R. The Association of International Staging System (ISS) Stage with Disease and Symptom Burden in Patients with Newly Diagnosed Multiple Myeloma Blood. 126: 2115-2115. DOI: 10.1182/Blood.V126.23.2115.2115 |
0.319 |
|
| 2015 |
Camp NJ, Waller RG, Garner C, Tricot GJ, Tomasson M, Atanackovic D, Glenn M. Elevated Rates of Monoclonal Gammopathy in High-Risk Chronic Lymphocytic Leukemia Pedigrees Blood. 126: 1449-1449. DOI: 10.1182/Blood.V126.23.1449.1449 |
0.328 |
|
| 2015 |
Gupta DS, Pan D, Hu G, Senpan A, Yang X, Prochownik EV, Lanza GM, Tomasson MH. Abstract B46: VLA-4 targeted nanoparticles carrying a novel anti-Myc prodrug prolongs survival in a mouse model of multiple myeloma. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-B46 |
0.313 |
|
| 2015 |
Mahajan N, Maggi LB, Tomasson MH, Weber JD. Abstract LB-298: The multiple-myeloma associated snoRNA, ACA11 increases oxidative stress and cell proliferation Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-298 |
0.339 |
|
| 2015 |
Rand KA, Song C, Dean E, Serie D, Curtin K, Hazelett D, Hwang AE, Sheng X, Stram A, Berg DJVD, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Roos AD, et al. Abstract 4629: Multiple myeloma susceptibility loci examined in African and European ancestry populations Cancer Research. 75: 4629-4629. DOI: 10.1158/1538-7445.Am2015-4629 |
0.311 |
|
| 2014 |
Miller CA, White BS, Dees ND, Griffith M, Welch JS, Griffith OL, Vij R, Tomasson MH, Graubert TA, Walter MJ, Ellis MJ, Schierding W, DiPersio JF, Ley TJ, Mardis ER, et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. Plos Computational Biology. 10: e1003665. PMID 25102416 DOI: 10.1371/Journal.Pcbi.1003665 |
0.347 |
|
| 2014 |
Wang TF, Ahluwalia R, Fiala MA, Trinkaus KM, Cox DP, Jaenicke M, Moliske CC, Carson KR, Wildes TM, Tomasson MH, Stockerl-Goldstein KE, Vij R. The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide. Leukemia & Lymphoma. 55: 337-41. PMID 23662990 DOI: 10.3109/10428194.2013.803547 |
0.339 |
|
| 2014 |
Fiala MA, Keller J, Stockerl-Goldstein KE, Tomasson MH, Vij R, Wildes TM. Front-Line Radiotherapy Is Associated with Shortened Survival in Newly Diagnosed Multiple Myeloma Patients Blood. 124: 5696-5696. DOI: 10.1182/Blood.V124.21.5696.5696 |
0.345 |
|
| 2014 |
Fiala MA, Keller J, Stockerl-Goldstein KE, Tomasson MH, Vij R, Wildes TM. Treatment Advances for Multiple Myeloma Have Disproportionally Benefited Patients Who Are Young, White, and Have Higher Socioeconomic Status Blood. 124: 555-555. DOI: 10.1182/Blood.V124.21.555.555 |
0.327 |
|
| 2014 |
Amend S, Wilson WC, Chu L, Serie D, Vachon CM, Lu L, Su X, Hurchla MA, Wang D, Liu P, Vij R, Colditz GA, Weilbaecher KN, Tomasson MH. Inherited Loss of Samsn1 Contributes to Increased Risk of MGUS and MM through Effects on Multiple Cell Types, Including B-Cells, Transformed Myeloma Cells, and Macrophages Blood. 124: 2075-2075. DOI: 10.1182/Blood.V124.21.2075.2075 |
0.393 |
|
| 2014 |
Hwang AE, Ailwadhi S, Huff CA, Bernal-Mizrachi L, Haiman CA, Peters E, Singhal S, Pawlish K, Bock C, Zimmerman T, Berg DJVD, Conti DV, Birmann BB, Mehta J, Graff JJ, ... ... Tomasson M, et al. Abstract 3852: Obesity is associated with clinical characteristics in African American multiple myeloma patients Cancer Research. 74: 3852-3852. DOI: 10.1158/1538-7445.Am2014-3852 |
0.301 |
|
| 2013 |
Mullins CD, Su MY, Hucthagowder V, Chu L, Lu L, Kulkarni S, Novack D, Vij R, Tomasson MH. Germinal center B-cells resist transformation by Kras independently of tumor suppressor Arf. Plos One. 8: e67941. PMID 23825691 DOI: 10.1371/Journal.Pone.0067941 |
0.391 |
|
| 2013 |
Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson G, Hoadley K, Triche TJ, Laird PW, Baty JD, Fulton LL, Fulton R, Heath SE, Kalicki-Veizer J, Kandoth C, ... ... Tomasson MH, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia New England Journal of Medicine. 368: 2059-2074. PMID 23634996 DOI: 10.1056/Nejmoa1301689 |
0.328 |
|
| 2013 |
Soodgupta D, Hurchla MA, Jiang M, Zheleznyak A, Weilbaecher KN, Anderson CJ, Tomasson MH, Shokeen M. Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma. Plos One. 8: e55841. PMID 23409060 DOI: 10.1371/Journal.Pone.0055841 |
0.325 |
|
| 2013 |
Hurchla MA, Garcia-Gomez A, Hornick MC, Ocio EM, Li A, Blanco JF, Collins L, Kirk CJ, Piwnica-Worms D, Vij R, Tomasson MH, Pandiella A, San Miguel JF, Garayoa M, Weilbaecher KN. The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects. Leukemia. 27: 430-40. PMID 22763387 DOI: 10.1038/Leu.2012.183 |
0.323 |
|
| 2013 |
Wildes TM, Paasch J, Fiala MA, Chen L, Vij R, Stockerl-Goldstein KE, Stewart S, Colditz GA, Tomasson M. The Senescence-Associated Secretory Phenotype In Multiple Myeloma Blood. 122: 5357-5357. DOI: 10.1182/Blood.V122.21.5357.5357 |
0.334 |
|
| 2013 |
Amend S, Chu L, Serie D, Vachon CM, Lu L, Vij R, Colditz GA, Weilbaecher KN, Tomasson MH. Deletion Of Samsn1 Underlies Genetic Susceptibility To Monoclonal Gammopathy Of Undetermined Significance (MGUS) In Mice Blood. 122: 397-397. DOI: 10.1182/Blood.V122.21.397.397 |
0.405 |
|
| 2013 |
Ghobadi A, Fiala MA, Abboud CN, Cashen AF, Eissenberg L, Graubert T, Jacoby MA, Pusic I, Schroeder MA, Stockerl-Goldstein KE, Tomasson MH, Uy GL, Vij R, Walter MJ, DiPersio JF, et al. A Phase I Study Of Azacitidine After Donor Lymphocyte Infusion For Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation Blood. 122: 3320-3320. DOI: 10.1182/Blood.V122.21.3320.3320 |
0.381 |
|
| 2013 |
Sanfilippo KM, Gage BF, Luo S, Vij R, Tomasson MH, Weilbaecher KN, Carson KR. Zoledronic Acid Improves Overall Survival Compared To Pamidronate In Multiple Myeloma Blood. 122: 3182-3182. DOI: 10.1182/Blood.V122.21.3182.3182 |
0.375 |
|
| 2013 |
Dees ND, Miller CA, White BS, Schierding W, Vij R, Tomasson MH, Welch JS, Graubert TA, Walter MJ, Ley TJ, DiPersio JF, Mardis ER, Wilson RK, Ding L. Abstract LB-232: Tumor clonality detection using next generation sequencing data. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-232 |
0.326 |
|
| 2012 |
Hucthagowder V, Meyer R, Mullins C, Nagarajan R, DiPersio JF, Vij R, Tomasson MH, Kulkarni S. Resequencing analysis of the candidate tyrosine kinase and RAS pathway gene families in multiple myeloma. Cancer Genetics. 205: 474-8. PMID 22939401 DOI: 10.1016/J.Cancergen.2012.06.007 |
0.377 |
|
| 2012 |
Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, Wartman LD, Lamprecht TL, Liu F, Xia J, Kandoth C, Fulton RS, McLellan MD, Dooling DJ, Wallis JW, ... ... Tomasson MH, et al. The origin and evolution of mutations in acute myeloid leukemia. Cell. 150: 264-78. PMID 22817890 DOI: 10.1016/J.Cell.2012.06.023 |
0.383 |
|
| 2012 |
Chu L, Su MY, Maggi LB, Lu L, Mullins C, Crosby S, Huang G, Chng WJ, Vij R, Tomasson MH. Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress. The Journal of Clinical Investigation. 122: 2793-806. PMID 22751105 DOI: 10.1172/Jci63051 |
0.34 |
|
| 2012 |
Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, Larson DE, McLellan MD, Dooling D, Abbott R, Fulton R, Magrini V, Schmidt H, Kalicki-Veizer J, O'Laughlin M, ... ... Tomasson M, et al. Clonal architecture of secondary acute myeloid leukemia. The New England Journal of Medicine. 366: 1090-8. PMID 22417201 DOI: 10.1056/Nejmoa1106968 |
0.377 |
|
| 2012 |
Bunting KD, Qu CK, Tomasson MH. Molecular-targeted therapies for hematologic malignancies. Advances in Hematology. 2012: 606423. PMID 22242021 DOI: 10.1155/2012/606423 |
0.355 |
|
| 2012 |
Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, McMichael JF, Wallis JW, Lu C, Shen D, Harris CC, ... ... Tomasson MH, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 481: 506-10. PMID 22237025 DOI: 10.1038/Nature10738 |
0.389 |
|
| 2012 |
Graubert TA, Shen D, Ding L, Okeyo-Owuor T, Lunn CL, Shao J, Krysiak K, Harris CC, Koboldt DC, Larson DE, McLellan MD, Dooling DJ, Abbott RM, Fulton RS, Schmidt H, ... ... Tomasson MH, et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nature Genetics. 44: 53-7. PMID 22158538 DOI: 10.1038/Ng.1031 |
0.364 |
|
| 2012 |
Mullins CD, Su MY, Hucthagowder V, Chu L, Lu L, Kulkarni S, Vij R, Tomasson MH. Activation of K-Ras in Arf-Null Mice Is Not Sufficient for Malignant Transformation of Post-Germinal Center B-Cells Blood. 120: 5016-5016. DOI: 10.1182/Blood.V120.21.5016.5016 |
0.305 |
|
| 2012 |
Wang T, Fiala M, Ahluwalia R, Trinkaus K, Moliske C, Cox D, Jaenicke M, Stockerl-Goldstein K, Wildes T, Carson KR, Tomasson MH, Vij R. The Demographics and Outcomes of Patients with Multiple Myeloma Dual Refractory to or Intolerant of Bortezomib and Lenalidomide in the Era of Carfilzomib and Pomalidomide Blood. 120: 4050-4050. DOI: 10.1182/Blood.V120.21.4050.4050 |
0.354 |
|
| 2012 |
Cozen W, Hwang AE, Ailawadhi S, Singhal S, Huff CA, Bernal-Mizrachi L, Chiu BC, Brown EE, Peters E, Pawlish K, Ann M, Bock CH, Haiman C, Stram DO, Rand KA, ... Tomasson MH, et al. Explaining the Excess Risk of Multiple Myeloma in African-Americans Blood. 120: 4002-4002. DOI: 10.1182/Blood.V120.21.4002.4002 |
0.351 |
|
| 2012 |
Hucthagowder V, Fiala M, Cox D, Stockerl-Goldstein KE, Tomasson MH, DiPersio JF, Vij R, Kulkarni S. Genome-Wide Copy Number Analyses Correlated with Outcomes in Untreated Multiple Myeloma Patients Blood. 120: 3991-3991. DOI: 10.1182/Blood.V120.21.3991.3991 |
0.378 |
|
| 2012 |
Tomasson MH, Shen D, Hucthagowder V, Schierding W, Mullins CD, Fiala M, Hall IM, Wallis J, Fulton RS, Fulton LA, Kulkarni S, Mardis ER, Wilson RK, Ley TJ, DiPersio JF, et al. Whole Genome Sequencing Reveals Novel Recurring Somatic Mutations Affecting HUWE1 and DIAPH2 Genes in Multiple Myeloma Blood. 120: 320-320. DOI: 10.1182/Blood.V120.21.320.320 |
0.439 |
|
| 2012 |
He Z, Wang Y, Luo J, Lu L, Su MY, Vij R, Bhattacharya D, Tomasson MH. Rb Protects B-Lineage Hematopoietic Progenitor Cells From Oxidative Stress and Exhaustion Blood. 120: 1315-1315. DOI: 10.1182/Blood.V120.21.1315.1315 |
0.382 |
|
| 2011 |
Welch JS, Westervelt P, Ding L, Larson DE, Klco JM, Kulkarni S, Wallis J, Chen K, Payton JE, Fulton RS, Veizer J, Schmidt H, Vickery TL, Heath S, Watson MA, ... Tomasson MH, et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. Jama. 305: 1577-84. PMID 21505136 DOI: 10.1001/Jama.2011.497 |
0.329 |
|
| 2011 |
Wartman LD, Larson DE, Xiang Z, Ding L, Chen K, Lin L, Cahan P, Klco JM, Welch JS, Li C, Payton JE, Uy GL, Varghese N, Ries RE, Hoock M, ... ... Tomasson MH, et al. Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression. The Journal of Clinical Investigation. 121: 1445-55. PMID 21436584 DOI: 10.1172/Jci45284 |
0.41 |
|
| 2011 |
Hucthagowder V, Shaik J, Fiala M, Paasch J, Nagarajan R, Stockerl-Goldstein KE, DiPersio JF, Tomasson MH, Vij R, Kulkarni S. Genomic Landscape of Immunoglobulin Light Chain (AL) Amyloidosis and Comparative Analyses with Related Malignant Plasma Cell Disorder- Multiple Myeloma Blood. 118: 809-809. DOI: 10.1182/Blood.V118.21.809.809 |
0.358 |
|
| 2011 |
Welch JS, Larson D, Ding L, McLellan MD, Lamprecht T, Kandoth C, Payton JE, Baty J, Harris CC, Lichti CF, Fulton RS, Dooling DJ, Koboldt DC, Schmidt H, Zhang Q, ... ... Tomasson MH, et al. Complete Sequencing and Comparison of 12 Normal Karyotype M1 AML Genomes with 12 t(15;17) Positive M3-APL Genomes Blood. 118: 404-404. DOI: 10.1182/Blood.V118.21.404.404 |
0.377 |
|
| 2011 |
Hurchla MA, Garcia-Gomez A, Hornick MC, Ocio EM, Li A, Blanco JF, Collins L, Kirk CJ, Piwnica-Worms D, Vij R, Tomasson MH, Pandiella A, San Miguel JF, Garayoa M, Weilbaecher KN. Epoxyketone-Based Proteasome Inhibitors Carfilzomib and Orally Bioavailable ONX 0912 Have Anti-Resorptive and Bone-Anabolic Activity in Addition to Anti-Myeloma Effects Blood. 118: 2906-2906. DOI: 10.1182/Blood.V118.21.2906.2906 |
0.387 |
|
| 2011 |
Kulkarni S, Elliott N, Fiala M, Paasch J, Tomasson MH, Stockerl-Goldstein KE, DiPersio JF, Geiss G, Vij R, Hucthagowder V. High Throughput Digital Quantification of Genomic Copy Number Alterations in Multiple Myeloma Blood. 118: 1830-1830. DOI: 10.1182/Blood.V118.21.1830.1830 |
0.395 |
|
| 2011 |
Hurchla MA, Hornick MC, Li A, Collins L, Kirk CJ, Piwnica-Worms D, Vij R, Tomasson MH, Weilbaecher KN. Abstract 541: The oral proteasome inhibitor ONX 0912 has bone anabolic effects in addition to anti-myeloma effects Cancer Research. 71: 541-541. DOI: 10.1158/1538-7445.Am2011-541 |
0.355 |
|
| 2010 |
Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J, Welch J, Harris CC, Lichti CF, Townsend RR, Fulton RS, Dooling DJ, ... ... Tomasson MH, et al. DNMT3A mutations in acute myeloid leukemia. The New England Journal of Medicine. 363: 2424-33. PMID 21067377 DOI: 10.1056/Nejmoa1005143 |
0.377 |
|
| 2010 |
Cheng M, Zhou J, Wu M, Boriboun C, Thorne T, Liu T, Xiang Z, Zeng Q, Tanaka T, Tang YL, Kishore R, Tomasson MH, Miller RJ, Losordo DW, Qin G. CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity. Circulation Research. 107: 1083-93. PMID 20847314 DOI: 10.1161/Circresaha.110.220970 |
0.324 |
|
| 2010 |
Xiang Z, Luo H, Payton JE, Cain J, Ley TJ, Opferman JT, Tomasson MH. Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia. The Journal of Clinical Investigation. 120: 2109-18. PMID 20484815 DOI: 10.1182/Blood.V114.22.764.764 |
0.423 |
|
| 2010 |
Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J, Welch JS, Harris CC, Lichti CF, Townsend RR, Fulton RS, Dooling DJ, ... ... Tomasson MH, et al. Mutations In the DNA Methyltransferase Gene DNMT3A Are Highly Recurrent In Patients with Intermediate Risk Acute Myeloid Leukemia, and Predict Poor Outcomes Blood. 116: 99-99. DOI: 10.1182/Blood.V116.21.99.99 |
0.388 |
|
| 2010 |
Hucthagowder V, Mullins CD, Meyer R, Nagarajan R, DiPersio JF, Vij R, Tomasson MH, Kulkarni S. Resequencing Analysis of the Human Candidate Ras and Receptor Tyrosine Kinase Gene Family In Multiple Myeloma Blood. 116: 301-301. DOI: 10.1182/Blood.V116.21.301.301 |
0.316 |
|
| 2010 |
Mullins CD, Tomasson M, Lu L, Su MY, Hutchagowder V, Vij R, Kulkarni S, Chu L. Germinal Center Specific Activation of K-Ras, Common In Multiple Myeloma, Is Selected Against and Is Not Sufficient to Initiate Plasma Cell Transformation In Mice Blood. 116: 137-137. DOI: 10.1182/Blood.V116.21.137.137 |
0.352 |
|
| 2009 |
Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, Fulton LA, Locke DP, Magrini VJ, Abbott RM, Vickery TL, ... ... Tomasson MH, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. The New England Journal of Medicine. 361: 1058-66. PMID 19657110 DOI: 10.1056/Nejmoa0903840 |
0.37 |
|
| 2009 |
Walter MJ, Payton JE, Ries RE, Shannon WD, Deshmukh H, Zhao Y, Baty J, Heath S, Westervelt P, Watson MA, Tomasson MH, Nagarajan R, O'Gara BP, Bloomfield CD, Mrózek K, et al. Acquired copy number alterations in adult acute myeloid leukemia genomes. Proceedings of the National Academy of Sciences of the United States of America. 106: 12950-5. PMID 19651600 DOI: 10.1073/Pnas.0903091106 |
0.336 |
|
| 2009 |
Tomasson MH. Cancer stem cells: a guide for skeptics. Journal of Cellular Biochemistry. 106: 745-9. PMID 19184979 DOI: 10.1002/Jcb.22050 |
0.315 |
|
| 2009 |
O'Neal J, Gao F, Hassan A, Monahan R, Barrios S, Kilimann MW, Lee I, Chng WJ, Vij R, Tomasson MH. Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma. Experimental Hematology. 37: 234-44. PMID 19135901 DOI: 10.1016/J.Exphem.2008.10.014 |
0.58 |
|
| 2009 |
Uy GL, Goyal SD, Fisher NM, Oza AY, Tomasson MH, Stockerl-Goldstein K, DiPersio JF, Vij R. Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: A single institution phase II study Bone Marrow Transplantation. 43: 793-800. PMID 19029964 DOI: 10.1038/Bmt.2008.384 |
0.361 |
|
| 2009 |
Wartman LD, Ding L, Larson DE, McLellan MD, Schmidt H, Xiang Z, Tomasson M, Mardis E, Wilson RK, Ley TJ. DNA Sequencing of a Murine Acute Promyelocytic Leukemia (APL) Genome Using Next Generation Technology. Blood. 114: 3965-3965. DOI: 10.1182/Blood.V114.22.3965.3965 |
0.415 |
|
| 2008 |
Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, Dooling D, Dunford-Shore BH, McGrath S, Hickenbotham M, Cook L, Abbott R, Larson DE, Koboldt DC, Pohl C, ... ... Tomasson MH, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 456: 66-72. PMID 18987736 DOI: 10.1038/Nature07485 |
0.375 |
|
| 2008 |
Liu F, Kunter G, Krem MM, Eades WC, Cain JA, Tomasson MH, Hennighausen L, Link DC. Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5. The Journal of Clinical Investigation. 118: 946-55. PMID 18292815 DOI: 10.1172/Jci32704 |
0.365 |
|
| 2008 |
Tomasson MH, Xiang Z, Walgren R, Zhao Y, Kasai Y, Miner T, Ries RE, Lubman O, Fremont DH, McLellan MD, Payton JE, Westervelt P, DiPersio JF, Link DC, Walter MJ, et al. Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood. 111: 4797-808. PMID 18270328 DOI: 10.1182/Blood-2007-09-113027 |
0.398 |
|
| 2008 |
Wernig G, Gonneville JR, Crowley BJ, Rodrigues MS, Reddy MM, Hudon HE, Walz C, Reiter A, Podar K, Royer Y, Constantinescu SN, Tomasson MH, Griffin JD, Gilliland DG, Sattler M. The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes. Blood. 111: 3751-9. PMID 18216297 DOI: 10.1182/Blood-2007-07-102186 |
0.349 |
|
| 2008 |
Xiang Z, Zhao Y, Mitaksov V, Fremont DH, Kasai Y, Molitoris A, Ries RE, Miner TL, McLellan MD, DiPersio JF, Link DC, Payton JE, Graubert TA, Watson M, Shannon W, ... ... Tomasson MH, et al. Identification of somatic JAK1 mutations in patients with acute myeloid leukemia. Blood. 111: 4809-12. PMID 18160671 DOI: 10.1182/Blood-2007-05-090308 |
0.405 |
|
| 2007 |
Fong T, Trinkaus K, Adkins D, Vij R, Devine SM, Tomasson M, Goodnough LT, Lopez S, Graubert T, Shenoy S, DiPersio JF, Khoury HJ. A Randomized Double-Blind Trial of Hydroxychloroquine for the Prevention of Chronic Graft-versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 13: 1201-1206. PMID 17889357 DOI: 10.1016/J.Bbmt.2007.06.012 |
0.327 |
|
| 2007 |
Link DC, Kunter G, Kasai Y, Zhao Y, Miner T, McLellan MD, Ries RE, Kapur D, Nagarajan R, Dale DC, Bolyard AA, Boxer LA, Welte K, Zeidler C, Donadieu J, ... ... Tomasson MH, et al. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood. 110: 1648-55. PMID 17494858 DOI: 10.1182/Blood-2007-03-081216 |
0.381 |
|
| 2007 |
Cain JA, Xiang Z, O'Neal J, Kreisel F, Colson A, Luo H, Hennighausen L, Tomasson MH. Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage Blood. 109: 3906-3914. PMID 17218386 DOI: 10.1182/Blood-2006-07-036335 |
0.61 |
|
| 2007 |
Xiang Z, Kreisel F, Cain J, Colson A, Tomasson MH. Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling Molecular and Cellular Biology. 27: 267-282. PMID 17060458 DOI: 10.1128/Mcb.01153-06 |
0.316 |
|
| 2007 |
Fehniger TA, Nelson A, Trinkaus K, Abboud CN, Cashen AF, DiPersio JF, Graubert TA, Ley TJ, Tomasson MH, Uy GL, Walter MJ, Westervelt P, Vij R. Phase II Study of High Dose Lenalidomide as Initial Treatment for Older Acute Myeloid Leukemia Patients: Early Results Show a Significant Reduction of Bone Marrow Blasts after 14 Days of Therapy. Blood. 110: 916-916. DOI: 10.1182/Blood.V110.11.916.916 |
0.34 |
|
| 2007 |
Xiang Z, Zhao Y, Mitaksov V, Fremont DH, Kasai Y, Molitoris A, Ries RE, Miner T, McLellan MD, DiPersio JF, Link DC, Payton JE, Graubert TA, Watson M, Shannon W, ... ... Tomasson MH, et al. Identification of Novel, Non-Synonymous Sequence Changes in the Tyrosine Kinase Genes of Patients with Acute Myeloid Leukemia. Blood. 110: 823-823. DOI: 10.1182/Blood.V110.11.823.823 |
0.409 |
|
| 2007 |
Luo H, Cain JA, Molitoris A, Opferman J, Tomasson MH. Myc Induces Acute Myeloid Leukemia by Conferring Self-Renewal Activity to Committed Myeloid Progenitor Cells That Resist Apoptosis Via Endogenous Mcl-1. Blood. 110: 2634-2634. DOI: 10.1182/Blood.V110.11.2634.2634 |
0.428 |
|
| 2007 |
O’Neal J, Molitoris A, Gao F, Hassan A, Monahan R, Barrios S, Weilbaecher K, Vij R, Tomasson MH. Coordinate Interstitial Deletion of Retinoblastoma (RB1) and Neurobeachin (NBEA) Is a Recurring Event in Multiple Myeloma. Blood. 110: 2480-2480. DOI: 10.1182/Blood.V110.11.2480.2480 |
0.392 |
|
| 2007 |
Ley TJ, DiPersio J, Ding L, Ries R, Magrini V, Payton J, McGrath S, Walter M, Wylie T, Dunford-Shore B, Chen K, McLellan M, Wendl M, Dooling D, Cook L, ... ... Tomasson M, et al. Sequencing an Acute Myeloid Leukemia (AML) Genome with “Next Generation” Technologies. Blood. 110: 205-205. DOI: 10.1182/Blood.V110.11.205.205 |
0.378 |
|
| 2007 |
Walter MJ, Ries R, Li X, Shannon W, Payton J, Books J, Bloomfield C, Mrozek K, Ruppert A, DiPersio J, Link D, Tomasson M, Graubert T, Westervelt P, Watson M, et al. High Resolution Array-Based CGH and SNP Studies of AML Genomes. Blood. 110: 107-107. DOI: 10.1182/Blood.V110.11.107.107 |
0.36 |
|
| 2006 |
Peles S, Fisher NM, Gao F, Tomasson MH, Dipersio JF, Vij R. A prospective study of the effects of once weekly bortezomib on markers of bone metabolism in patients with multiple myeloma (MM) Journal of Clinical Oncology. 24: 7548-7548. DOI: 10.1200/Jco.2006.24.18_Suppl.7548 |
0.357 |
|
| 2005 |
Devine SM, Brown RA, Mathews V, Trinkaus K, Khoury H, Adkins D, Vij R, Sempek D, Graubert T, Tomasson M, Goodnough LT, DiPersio JF. Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone. Bone Marrow Transplantation. 36: 531-8. PMID 16025152 DOI: 10.1038/Sj.Bmt.1705091 |
0.306 |
|
| 2005 |
Luo H, Li Q, O'Neal J, Kreisel F, Le Beau MM, Tomasson MH. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood. 106: 2452-61. PMID 15972450 DOI: 10.1182/Blood-2005-02-0734 |
0.625 |
|
| 2005 |
Uy GL, Ruddell AM, Devine SM, Tomasson MH, DiPersio JF, Vij R. Low Dose Clofarabine Causes Significant Hematologic Toxicity in a Phase II Study of Relapsed or Refractory Multiple Myeloma. Blood. 106: 5170-5170. DOI: 10.1182/Blood.V106.11.5170.5170 |
0.32 |
|
| 2005 |
Peles S, Fisher NM, Gao F, Devine SM, Tomasson MH, DiPersio JF, Vij R. Once Weekly Bortezomib (Velcade) Preserves Bone Health by a Direct Effect on Osteoclast Function Independent of Its Effect on the Malignant Plasma Cells. Blood. 106: 3458-3458. DOI: 10.1182/Blood.V106.11.3458.3458 |
0.363 |
|
| 2005 |
Peles S, Fisher NM, Devine SM, Tomasson MH, DiPersio JF, Vij R. Bortezomib (Velcade) When Given Pretransplant and Once Weekly as Consolidation Therapy Following High Dose Chemotherapy (HDCT) Leads to High Rates of Reactivation of Varicella Zoster Virus (VZV). Blood. 106: 3237-3237. DOI: 10.1182/Blood.V106.11.3237.3237 |
0.366 |
|
| 2005 |
Uy GL, Fisher NM, Devine SM, Tomasson MH, DiPersio JF, Vij R. Bortezomib Does Not Impair Cytokine Induced Mobilization of Stem Cells Prior to Autologous Transplantation in Multiple Myeloma. Blood. 106: 2926-2926. DOI: 10.1182/Blood.V106.11.2926.2926 |
0.369 |
|
| 2005 |
Uy GL, Holt MS, Fisher NM, Devine SM, Tomasson MH, DiPersio JF, Vij R. Bortezomib Alters Peripheral Blood Lymphocyte Subsets in Patients with Multiple Myeloma. Blood. 106: 2387-2387. DOI: 10.1182/Blood.V106.11.2387.2387 |
0.325 |
|
| 2005 |
Walter MJ, Ries RR, Li XD, Shannon WJ, Payton J, Bloomfield CD, Mrozek K, Ruppert AS, DiPersio J, Link D, Tomasson M, Graubert T, McLeod H, Devine S, Watson M, et al. Detection of Microdeletions and Amplifications in Primary Human Acute Myeloid Leukemia (AML) Genomes Using Ultradense Oligomer Tiling Path Arrays and Comparative Genomic Hybridization (CGH). Blood. 106: 2350-2350. DOI: 10.1182/Blood.V106.11.2350.2350 |
0.335 |
|
| 2005 |
Xiang Z, Cain J, Kreisel F, Tomasson MH. Species-Specific Differences in Intracellular Transport Reveal a Golgi-Localization Requirement for D816V Mutant Kit Receptor To Induce Leukemia. Blood. 106: 1600-1600. DOI: 10.1182/Blood.V106.11.1600.1600 |
0.394 |
|
| 2005 |
Uy G, Fisher N, Devine S, Adkins D, Tomasson M, Graubert T, DiPersio J, Vij R. Bortezomib does not adversely affect stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation. 11: 77. DOI: 10.1016/J.Bbmt.2004.12.228 |
0.324 |
|
| 2004 |
Cain JA, Grisolano JL, Laird AD, Tomasson MH. Complete remission of TEL-PDGFRB-induced myeloproliferative disease in mice by receptor tyrosine kinase inhibitor SU11657. Blood. 104: 561-4. PMID 15044254 DOI: 10.1182/Blood-2003-11-3801 |
0.321 |
|
| 2004 |
Uy GL, Fisher NM, Devine SM, Khoury HJ, Adkins DR, Tomasson MH, Graubert TA, DiPersio JF, Vij R. Bortezomib Given in Sequence with Anthracycline and Thalidomide-Containing Regimens Does Not Adversely Affect Stem Cell Mobilization and Engraftment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation. Blood. 104: 541-541. DOI: 10.1182/Blood.V104.11.541.541 |
0.365 |
|
| 2004 |
Li Q, Luo H, O’Neal J, Kreisel F, Inoyama D, Le Beau MM, Tomasson M. Mutations Required for Lymphoid Leukemogenesis Are Not Required for c-Myc to Rapidly Induce Acute Myeloid Leukemia. Blood. 104: 483-483. DOI: 10.1182/Blood.V104.11.483.483 |
0.417 |
|
| 2003 |
Ley TJ, Minx PJ, Walter MJ, Ries RE, Sun H, McLellan M, DiPersio JF, Link DC, Tomasson MH, Graubert TA, McLeod H, Khoury H, Watson M, Shannon W, Trinkaus K, et al. A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes. Proceedings of the National Academy of Sciences of the United States of America. 100: 14275-80. PMID 14614138 DOI: 10.1073/Pnas.2335924100 |
0.39 |
|
| 2003 |
Bakewell SJ, Nestor P, Prasad S, Tomasson MH, Dowland N, Mehrotra M, Scarborough R, Kanter J, Abe K, Phillips D, Weilbaecher KN. Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proceedings of the National Academy of Sciences of the United States of America. 100: 14205-10. PMID 14612570 DOI: 10.1073/Pnas.2234372100 |
0.316 |
|
| 2003 |
Chohan R, Vij R, Adkins D, Blum W, Brown R, Tomasson M, Devine S, Graubert T, Goodnough LT, DiPersio JF, Khoury H. Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity. British Journal of Haematology. 123: 110-3. PMID 14510951 DOI: 10.1046/J.1365-2141.2003.04550.X |
0.314 |
|
| 2003 |
Grisolano JL, O'Neal J, Cain J, Tomasson MH. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice. Proceedings of the National Academy of Sciences of the United States of America. 100: 9506-11. PMID 12881486 DOI: 10.1073/Pnas.1531730100 |
0.62 |
|
| 2002 |
Dash AB, Williams IR, Kutok JL, Tomasson MH, Anastasiadou E, Lindahl K, Li S, Van Etten RA, Borrow J, Housman D, Druker B, Gilliland DG. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Proceedings of the National Academy of Sciences of the United States of America. 99: 7622-7. PMID 12032333 DOI: 10.1073/Pnas.102583199 |
0.402 |
|
| 2001 |
Sternberg DW, Tomasson MH, Carroll M, Curley DP, Barker G, Caprio M, Wilbanks A, Kazlauskas A, Gilliland DG. The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways. Blood. 98: 3390-7. PMID 11719379 DOI: 10.1182/Blood.V98.12.3390 |
0.336 |
|
| 2001 |
Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG, Van Etten RA. Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL Blood. 97: 1442-1450. PMID 11222392 DOI: 10.1182/Blood.V97.5.1442 |
0.3 |
|
| 2001 |
Tomasson MH, Williams IR, Li S, Kutok J, Cain D, Gillessen S, Dranoff G, Van Etten RA, Gilliland DG. Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3 Blood. 97: 1435-1441. PMID 11222391 DOI: 10.1182/Blood.V97.5.1435 |
0.357 |
|
| 2000 |
Tomasson MH, Sternberg DW, Williams IR, Carroll M, Cain D, Aster JC, Ilaria RL, Van Etten RA, Gilliland DG. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581. The Journal of Clinical Investigation. 105: 423-32. PMID 10683371 DOI: 10.1172/Jci8902 |
0.398 |
|
| 1999 |
Tomasson MH, Williams IR, Hasserjian R, Udomsakdi C, McGrath SM, Schwaller J, Druker B, Gilliland DG. TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor Blood. 93: 1707-1714. PMID 10029600 DOI: 10.1182/Blood.V93.5.1707 |
0.371 |
|
| 1998 |
Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaia R, Marynen P, Gilliland DG. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes Embo Journal. 17: 5321-5333. PMID 9736611 DOI: 10.1093/Emboj/17.18.5321 |
0.38 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2013 |
Rand KA, Camp N, Martino A, Dean EW, Serie DJ, Edlund CK, Hu D, Curtin K, Huntsman S, Van Den Berg DJ, De Roos A, Brown EE, Giles GG, Spinelli JJ, Ailawadhi S, ... ... Tomasson MH, et al. A Meta-Analysis Of Genome-Wide Association Studies Of Multiple Myeloma In Cases and Controls Of European Origin Identifies a Risk Locus In 12q23.1 Blood. 122: 3111-3111. DOI: 10.1182/Blood.V122.21.3111.3111 |
0.299 |
|
| 2017 |
Hao M, Machin RF, Xu H, Shaughnessy J, Barlogie B, Roodman D, Quelle DE, Janz S, Tomasson MH, Sanderson RD, Qiu L, Frech I, Tricot G, Zhan F. NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. Leukemia. PMID 28400617 DOI: 10.1038/Leu.2017.115 |
0.298 |
|
| 2016 |
Soodgupta D, Zhou H, Beaino W, Lu L, Snee M, Skeath J, DiPersio JF, Akers WJ, Laforest R, Anderson CJ, Tomasson MH, Shokeen M. Ex vivo and in vivo evaluation of over-expressed VLA-4 in multiple myeloma using LLP2A imaging agents. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26742713 DOI: 10.2967/Jnumed.115.164624 |
0.297 |
|
| 2018 |
Tomasson MH, Ali M, De Oliveira V, Xiao Q, Jethava Y, Zhan F, Fitzsimmons AM, Bates ML. Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma. International Journal of Molecular Sciences. 19. PMID 30453544 DOI: 10.3390/Ijms19113621 |
0.297 |
|
| 2014 |
Rand KA, Song C, Hwang AE, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Van Den Berg DJ, Sheng X, Graff JJ, Conti DV, Zimmerman T, Peters E, Singhal S, Bock CH, et al. Genetic Susceptibility Markers of Multiple Myeloma in African-Americans Blood. 124: 2030-2030. DOI: 10.1182/Blood.V124.21.2030.2030 |
0.297 |
|
| 2013 |
Hwang AE, Ailawadhi S, Bernal-Mizrachi L, Zimmerman TM, Haiman C, Van Den Berg DJ, Pawlish K, Mohrbacher AM, Terebelo H, Birmann BM, Stram DO, Conti DV, Janakiraman N, Henderson BE, Kolonel LN, ... ... Tomasson MH, et al. Obesity In Young Adulthood Is Associated With Early Onset Multiple Myeloma In African Americans Blood. 122: 1872-1872. DOI: 10.1182/Blood.V122.21.1872.1872 |
0.297 |
|
| 2015 |
Sanfilippo KM, Gage B, Luo S, Weilbaecher K, Tomasson M, Vij R, Colditz G, Carson K. Comparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma. Leukemia & Lymphoma. 56: 615-21. PMID 24844358 DOI: 10.3109/10428194.2014.924117 |
0.295 |
|
| 2015 |
Soodgupta D, Pan D, Cui G, Senpan A, Yang X, Lu L, Weilbaecher KN, Prochownik EV, Lanza GM, Tomasson MH. Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma. Molecular Cancer Therapeutics. 14: 1286-94. PMID 25824336 DOI: 10.1158/1535-7163.Mct-14-0774-T |
0.295 |
|
| 2020 |
Du Z, Weinhold N, Song GC, Rand KA, Van Den Berg DJ, Hwang AE, Sheng X, Hom V, Ailawadhi S, Nooka AK, Singhal S, Pawlish K, Peters ES, Bock C, Mohrbacher A, ... ... Tomasson M, et al. A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry. Blood Advances. 4: 181-190. PMID 31935283 DOI: 10.1182/Bloodadvances.2019000491 |
0.293 |
|
| 2016 |
Tang M, Zhao R, van de Velde H, Tross JG, Mitsiades CS, Viselli S, Neuwirth R, Esseltine DL, Anderson KC, Ghobrial IM, San Miguel J, Richardson PG, Tomasson MH, Michor F. Myeloma cell dynamics in response to treatment supports a model of hierarchical differentiation and clonal evolution. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27006493 DOI: 10.1158/1078-0432.Ccr-15-2793 |
0.292 |
|
| 2019 |
Sun F, Cheng Y, Walsh SA, Acevedo MR, Jing X, Han SS, Pisano MD, Tomasson MH, Lichtenstein AK, Zhan F, Hari P, Janz S. Osteolytic disease in IL-6 and Myc dependent mouse model of human myeloma. Haematologica. PMID 31221780 DOI: 10.3324/Haematol.2019.221127 |
0.292 |
|
| 2014 |
Soodgupta D, Pan D, Cui G, Senpan A, Yang X, Wickline SA, Prochownik EV, Weilbaecher KN, Tomasson MH, Lanza GM. Abstract 5381: VLA-4 targeted nanoparticles deliver a cMYC-MAX prodrug antagonist extends survival a metastatic myeloma mouse model Cancer Research. 74: 5381-5381. DOI: 10.1158/1538-7445.Am2014-5381 |
0.29 |
|
| 2016 |
Fiala MA, Dukeman J, Stockerl-Goldstein K, Tomasson MH, Wildes TM, Auclair D, Vij R. Next Generation Sequencing Based Revised International Staging System (R-ISS) for Multiple Myeloma Blood. 128: 2349-2349. DOI: 10.1016/J.Clml.2017.03.030 |
0.289 |
|
| 1999 |
Shen H, Cheng T, Preffer FI, Dombkowski D, Tomasson MH, Golan DE, Yang O, Hofmann W, Sodroski JG, Luster AD, Scadden DT. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. Journal of Virology. 73: 728-37. PMID 9847379 DOI: 10.1128/Jvi.73.1.728-737.1999 |
0.287 |
|
| 2012 |
Sanfilippo KM, Beason T, Chang S, Luo S, Colditz GA, Vij R, Tomasson MH, Ganti A, Carson KR. Effect of Body Mass Index (BMI) At Diagnosis On Survival Patterns of Multiple Myeloma (MM) Patients in the Veterans Health Administration (VHA). Blood. 120: 3182-3182. DOI: 10.1182/Blood.V120.21.3182.3182 |
0.285 |
|
| 2007 |
Uy GL, Trivedi R, Peles S, Fisher NM, Zhang QJ, Tomasson MH, DiPersio JF, Vij R. Bortezomib inhibits osteoclast activity in patients with multiple myeloma. Clinical Lymphoma & Myeloma. 7: 587-9. PMID 18186967 DOI: 10.3816/Clm.2007.N.045 |
0.276 |
|
| 2013 |
Soodgupta D, Pan D, Hu G, Senpan A, Yang X, Weilbaecher KN, Prochownik EV, Lanza GM, Tomasson MH. Preclinical Development Of a Nanomedicne Approach For Multiple Myeloma Targeting The Myc Oncoprotein Blood. 122: 4228-4228. DOI: 10.1182/Blood.V122.21.4228.4228 |
0.273 |
|
| 2014 |
Fiala MA, Finney JD, Liu J, Stockerl-Goldstein K, Tomasson MH, Vij R, Wildes TM. The impact of race and socioeconomic status on survival in multiple myeloma. Journal of Clinical Oncology. 32: e17554-e17554. DOI: 10.1200/Jco.2014.32.15_Suppl.E17554 |
0.273 |
|
| 2014 |
Keller J, Fiala MA, Sekhar J, Ceriotti C, Allen M, Abboud CN, Stockerl-Goldstein KE, Wildes TM, Tomasson MH, Vij R. A Phase I Study of Carfilzomib and Pegylated Liposomal Doxorubicin for Relapsed or Refractory Multiple Myeloma Blood. 124: 4731-4731. DOI: 10.1182/Blood.V124.21.4731.4731 |
0.271 |
|
| 2015 |
Pan D, Kim B, Hu G, Gupta DS, Senpan A, Yang X, Schmieder A, Swain C, Wickline SA, Tomasson MH, Lanza GM. A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy. Nanomedicine (London, England). 10: 241-51. PMID 25600969 DOI: 10.2217/Nnm.14.101 |
0.27 |
|
| 2020 |
Du Z, Weinhold N, Song GC, Rand KA, Berg DJVD, Hwang AE, Sheng X, Hom V, Ailawadhi S, Nooka AK, Singhal S, Pawlish K, Peters E, Bock C, Mohrbacher A, ... ... Tomasson M, et al. Abstract PR05: A meta-analysis of genome-wide association study and eQTL analysis of multiple myeloma among African Americans Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-Pr05 |
0.27 |
|
| 2013 |
Beason TS, Chang SH, Sanfilippo KM, Luo S, Colditz GA, Vij R, Tomasson MH, Dipersio JF, Stockerl-Goldstein K, Ganti A, Wildes T, Carson KR. Influence of body mass index on survival in veterans with multiple myeloma. The Oncologist. 18: 1074-9. PMID 24048366 DOI: 10.1634/Theoncologist.2013-0015 |
0.268 |
|
| 2006 |
Uy G, Peles S, Fisher N, Tomasson M, DiPersio J, Vij R. Bortezomib prior to autologous transplant in multiple myeloma: Effects on mobilization, engraftment, and markers of immune function Biology of Blood and Marrow Transplantation. 12: 116. DOI: 10.1016/J.Bbmt.2005.11.355 |
0.264 |
|
| 2019 |
Goldsmith SR, Fiala MA, Dukeman J, Ghobadi A, Stockerl-Goldstein K, Schroeder MA, Tomasson M, Wildes TM, Vij R. Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study. Clinical Lymphoma, Myeloma & Leukemia. PMID 30792096 DOI: 10.1016/J.Clml.2019.01.003 |
0.261 |
|
| 2014 |
Carson KR, Bates ML, Tomasson MH. The skinny on obesity and plasma cell myeloma: a review of the literature. Bone Marrow Transplantation. 49: 1009-15. PMID 24820216 DOI: 10.1038/Bmt.2014.71 |
0.256 |
|
| 2000 |
TOMASSON MH, STERNBERG D, WILLIAMS I, CARROLL M, CAIN D, ASTER J, GILLILAND DG. 35. A Murine Bone Marrow Transplantation Model for TEL/PDGFβR Induced Myeloproliferative Disease: Requirement for Tyrosines 579/581 of PDGFβR Proceedings of the Japanese Society of Animal Models For Human Diseases. 16: 42-42. DOI: 10.1538/Expanim1992.16.42 |
0.254 |
|
| 2015 |
Fiala MA, Keller J, Slade M, Stockerl-Goldstein K, Tomasson M, Vij R, Wildes TM. The Association Between Performance Status and Health-Related Quality of Life Blood. 126: 3312-3312. DOI: 10.1182/Blood.V126.23.3312.3312 |
0.252 |
|
| 2018 |
Gu C, Holman C, Sompallae R, Jing X, Tomasson M, Hose D, Seckinger A, Zhan F, Tricot G, Goldschmidt H, Yang Y, Janz S. Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome. Blood Cancer Journal. 8: 22. PMID 29449574 DOI: 10.1038/S41408-018-0060-0 |
0.251 |
|
| 2017 |
Fiala M, Dukeman J, Stockerl-Goldstein K, Tomasson M, Wildes T, Vij R. The Real-World Characteristics and Outcomes of Newly Diagnosed Myeloma Patients Ineligible for Clinical Trials Clinical Lymphoma Myeloma and Leukemia. 17: e55-e56. DOI: 10.1016/J.Clml.2017.03.101 |
0.246 |
|
| 2016 |
Fiala MA, Dukeman J, Stockerl-Goldstein K, Tomasson MH, Wildes TM, Vij R. The Real-World Characteristics and Outcomes of Newly Diagnosed Myeloma Patients Ineligible for Clinical Trials Blood. 128: 2350-2350. DOI: 10.1182/blood.v128.22.2350.2350 |
0.246 |
|
| 2022 |
Dhakal P, Bates M, Tomasson MH, Sutamtewagul G, Dupuy A, Bhatt VR. Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold? Blood Reviews. 101036. PMID 36549969 DOI: 10.1016/j.blre.2022.101036 |
0.245 |
|
| 2006 |
Peles S, Uy G, Fisher N, Tomasson M, DiPersio J, Vij R. High rates of reactivation of varicella zoster virus (VZV) associated with bortezomib (VELCADE) when given pre and post high dose chemotherapy (HDCT) Biology of Blood and Marrow Transplantation. 12: 116-117. DOI: 10.1016/J.Bbmt.2005.11.357 |
0.24 |
|
| 2015 |
Pan D, Pham CT, Weilbaecher KN, Tomasson MH, Wickline SA, Lanza GM. Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. PMID 26296541 DOI: 10.1002/Wnan.1355 |
0.237 |
|
| 2013 |
Soodgupta D, Hurchla MA, Jiang M, Zheleznyak A, Weilbaecher KN, Anderson CJ, Tomasson MH, Shokeen M. Correction: Very Late Antigen-4 (α4β1Integrin) Targeted PET Imaging of Multiple Myeloma Plos One. 8. DOI: 10.1371/Annotation/8532E291-73D3-461C-810D-0533Ccb1Eba0 |
0.225 |
|
| 2004 |
Hidalgo JD, Krone R, Rich MW, Blum K, Adkins D, Fan MY, Brown R, Devine S, Graubert T, Blum W, Tomasson M, Goodnough LT, Vij R, DiPersio J, Khoury H. Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: Incidence, risk factors and outcomes Bone Marrow Transplantation. 34: 615-619. PMID 15258562 DOI: 10.1038/sj.bmt.1704623 |
0.219 |
|
| 2023 |
Bahlis NJ, Costello CL, Raje NS, Levy MY, Dholaria B, Solh M, Tomasson MH, Damore MA, Jiang S, Basu C, Skoura A, Chan EM, Trudel S, Jakubowiak A, Gasparetto C, et al. Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nature Medicine. 29: 2570-2576. PMID 37783970 DOI: 10.1038/s41591-023-02589-w |
0.219 |
|
| 2023 |
Rogers KJ, Abukhiran IM, Syrbu S, Tomasson M, Bates M, Dhakal P, Bhagavathi S. Utilizing digital pathology and immunohistochemistry of p53 as an adjunct to molecular testing in myeloid disorders. Academic Pathology. 10: 100064. PMID 36970330 DOI: 10.1016/j.acpath.2022.100064 |
0.215 |
|
| 2005 |
Fong T, Trinkaus K, Adkins DR, Vij R, Devine S, Tomasson M, Goodnough LT, Graubert T, Shenoy S, DiPersio JF, Khoury HJ. A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation. Blood. 106: 1800-1800. DOI: 10.1182/blood.v106.11.1800.1800 |
0.195 |
|
| 2019 |
Oliveira V, Mahajan N, Bates ML, Tripathi C, Kim KQ, Zaher HS, Maggi LB, Tomasson MH. The snoRNA target of t(4;14) in multiple myeloma regulates ribosome biogenesis. Faseb Bioadvances. 1: 404-414. PMID 32095781 DOI: 10.1096/fba.2018-00075 |
0.194 |
|
| 2016 |
Gragert L, Hwang A, Bernal-Mizrachi L, Ailawadhi S, Singhal S, Vandenberg DJ, Sheng X, Stram A, Conti DV, Rand KA, Song C, Graff JJ, Janakiraman N, Mehta J, Stram DO, ... ... Tomasson MH, et al. HLA Haplotypes Are Associated with Multiple Myeloma Risk in the African American Multiple Myeloma Study (AAMMS) Blood. 128: 3250-3250. DOI: 10.1182/Blood.V128.22.3250.3250 |
0.187 |
|
| 2019 |
Strouse C, Nadiminti K, Claus J, Berns G, Schultz A, Mott SL, Vikas P, Tomasson M, Farooq U, Silverman M, Jethava Y. A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Older Recently Diagnosed Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783) Biology of Blood and Marrow Transplantation. 25: S385-S386. DOI: 10.1016/J.BBMT.2018.12.793 |
0.18 |
|
| 2023 |
Lesokhin AM, Tomasson MH, Arnulf B, Bahlis NJ, Miles Prince H, Niesvizky R, Rodrίguez-Otero P, Martinez-Lopez J, Koehne G, Touzeau C, Jethava Y, Quach H, Depaus J, Yokoyama H, Gabayan AE, et al. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results. Nature Medicine. PMID 37582952 DOI: 10.1038/s41591-023-02528-9 |
0.161 |
|
| 2006 |
Uy GL, Tomasson MH, Ruddell A, DiPersio JF, Vij R. The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma. Haematologica. 91: 1581-2. PMID 17043015 |
0.156 |
|
| 2016 |
Rand KA, Song C, Dean E, Serie DJ, Curtin K, Sheng X, Hu D, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailwadhi S, Singhal S, Pawlish KS, Peters ES, BLock CH, et al. A meta-analysis of multiple myeloma risk regions in African and European ancestry populations identifies putatively functional loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27587788 DOI: 10.1158/1055-9965.Epi-15-1193 |
0.144 |
|
| 2011 |
Tomasson M. Legal, ethical, and conceptual bottlenecks to the development of useful genomic tests. Annals of Health Law. 18: 231-60, 8 p. precedi. PMID 21950240 |
0.126 |
|
| 1996 |
Golub TR, McLean T, Stegmaier K, Carroll M, Tomasson M, Gilliland DG. The TEL gene and human leukemia. Biochimica Et Biophysica Acta. 1288: M7-10. PMID 8764840 DOI: 10.1016/0304-419x(96)00015-7 |
0.12 |
|
| 2018 |
Altrock PM, Ferlic J, Galla T, Tomasson MH, Michor F. Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening Strategies. Jco Clinical Cancer Informatics. 1-12. PMID 30652561 DOI: 10.1200/CCI.17.00131 |
0.117 |
|
| 2021 |
Pottebaum E, Warmoth A, Ayyappan S, Dickens DS, Jethava Y, Modi A, Tomasson MH, Carr LJ, Bates ML. Wearable Monitors Facilitate Exercise in Adult and Pediatric Stem Cell Transplant. Exercise and Sport Sciences Reviews. PMID 33927164 DOI: 10.1249/JES.0000000000000258 |
0.113 |
|
| 2023 |
Bates ML, Vasileva A, Flores LDM, Pryakhina Y, Buckman M, Tomasson MH, DeRuisseau LR. Sex Differences in Cardiovascular Disease and Dysregulation in Down Syndrome. American Journal of Physiology. Heart and Circulatory Physiology. PMID 36800509 DOI: 10.1152/ajpheart.00544.2022 |
0.108 |
|
| 2021 |
Amaza I, Kalra H, Eberlein M, Jethava Y, McDonell J, Wolfe B, Tomasson MH, Bates ML. Case Studies in Physiology: Untangling the cause of hypoxemia in an obese patient with acute leukemia. Journal of Applied Physiology (Bethesda, Md. : 1985). PMID 33955261 DOI: 10.1152/japplphysiol.00867.2020 |
0.104 |
|
| 1996 |
Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proceedings of the National Academy of Sciences of the United States of America. 93: 14845-50. PMID 8962143 DOI: 10.1073/pnas.93.25.14845 |
0.092 |
|
| 2017 |
Fiala M, Keller J, Sekhar J, Ceriotti C, Abboud C, DiPersio J, Tomasson M, Wildes T, Stockerl-Goldstein K, Vij R. A Phase II Study of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone [CDD] for Relapsed or Refractory Multiple Myeloma Clinical Lymphoma Myeloma and Leukemia. 17: e56. DOI: 10.1016/j.clml.2017.03.102 |
0.09 |
|
| 2017 |
Fiala M, Dukeman J, Stockerl-Goldstein K, Tomasson M, Wildes T, Auclair D, Vij R. Next Generation Sequencing Based Revised International Staging System (R-ISS) for Multiple Myeloma Clinical Lymphoma Myeloma and Leukemia. 17: e18. DOI: 10.1016/j.clml.2017.03.030 |
0.085 |
|
| 2023 |
Zhang Z, Kalra H, Delzell MC, Jedlicka CR, Vasilyev M, Vasileva A, Tomasson MH, Bates ML. CORP: Sources and degrees of variability in whole animal intermittent hypoxia experiments. Journal of Applied Physiology (Bethesda, Md. : 1985). PMID 36958346 DOI: 10.1152/japplphysiol.00643.2022 |
0.061 |
|
| 2021 |
Vasilyev M, Berschel MR, Tomasson MH, Bates ML. Viewpoint: Time to stop treating the heart as a single organ? Experimental Physiology. PMID 33728739 DOI: 10.1113/EP089497 |
0.043 |
|
| Hide low-probability matches. |